Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Reliance Global | RELI | Nov 27, 2024 | 1.53 | +6.99 |
Relmada Therapeutics | RLMD | Nov 27, 2024 | 2.90 | +6.62 |
RELX ADR | RELX | Nov 27, 2024 | 47.05 | +0.51 |
Remitly Global | RELY | Nov 27, 2024 | 20.83 | +0.10 |
Renaissance Ipo ETF | IPO | Nov 27, 2024 | 46.33 | -0.68 |
RenaissanceRe | RNR | Nov 27, 2024 | 285.44 | +1.08 |
RenaissanceRe G Pref | RNR-G | Nov 27, 2024 | 18.09 | +0.22 |
RenaissanceRe Holding F Pref | RNR-F | Nov 27, 2024 | 24.54 | +0.16 |
Renalytix ADR | RNLX | Nov 27, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 27, 2024 | 37.88 | -0.76 |
ReNew Energy Global A Shares | RNW | Nov 27, 2024 | 6.09 | +0.66 |
Renn Fund | RCG | Nov 27, 2024 | 2.51 | +1.62 |
Renovaro Biosciences | RENB | Nov 27, 2024 | 0.61 | +18.07 |
RenovoRx | RNXT | Nov 27, 2024 | 1.26 | -7.35 |
Rent The Runway A | RENT | Nov 27, 2024 | 9.99 | -0.60 |
Rentokil Initial ADR | RTO | Nov 27, 2024 | 25.71 | -1.12 |
Repare Therapeutics | RPTX | Nov 27, 2024 | 3.32 | +5.40 |
Repay A | RPAY | Nov 27, 2024 | 8.21 | +1.61 |
Repligen | RGEN | Nov 27, 2024 | 149.99 | +2.21 |
Replimune Group | REPL | Nov 27, 2024 | 14.05 | -2.29 |
ReposiTrak | TRAK | Nov 27, 2024 | 22.85 | -1.51 |
Republic Bancorp A | RBCAA | Nov 27, 2024 | 77.36 | +0.38 |
Republic Services | RSG | Nov 27, 2024 | 218.28 | -0.21 |
Research Frontiers | REFR | Nov 27, 2024 | 1.95 | +0.52 |
Research Solutions | RSSS | Nov 27, 2024 | 3.42 | -1.44 |
Reservoir Media | RSVR | Nov 27, 2024 | 9.27 | -0.22 |
ReShape Lifesciences | RSLS | Nov 27, 2024 | 5.75 | +1.23 |
Resideo Technologies | REZI | Nov 27, 2024 | 27.14 | -0.66 |
ResMed | RMD | Nov 27, 2024 | 249.33 | -0.26 |
Resources Connection | RGP | Nov 27, 2024 | 8.44 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.